EMA Authorised: Boey (trenibotulinumtoxinE) — AbbVie Limited

View source ↗

Summary

A new botulinum toxin product trenibotulinumtoxinE (Boey) by AbbVie Limited has been authorised in Europe for stress-related/psychological indications and cosme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cosmetic Aesthetic Indications
• Psychological Conditions
• Stress-related Disorders

Drugs mentioned

• Boey (trenibotulinumtoxinE)

Snippet

Status: Authorised. Therapeutic area: Stress, Psychological;Cosmetic Techniques. MAH: AbbVie Limited. Decision date: 15/07/2026